Citius Oncology (CTOR)

• Market cap: $96.9M
• 1 day: 6.42%
• 5 days: -7.94%
• 1 month: -18.88%
• 3 months: -38.95%
• 6 months: -5.69%
• Year to date: -2.52%
• 1 year: -1.69%
• 5 years: -88.5%
• 10 years: -88.5%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.